Vericel

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vericel and other ETFs, options, and stocks.

About VCEL

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. 

CEO
Dominick C. Colangelo
CEODominick C. Colangelo
Employees
398
Employees398
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1989
Founded1989
Employees
398
Employees398

VCEL Key Statistics

Market cap
1.64B
Market cap1.64B
Price-Earnings ratio
102.73
Price-Earnings ratio102.73
Dividend yield
Dividend yield
Average volume
545.03K
Average volume545.03K
High today
$33.47
High today$33.47
Low today
$32.20
Low today$32.20
Open price
$32.79
Open price$32.79
Volume
505.24K
Volume505.24K
52 Week high
$48.75
52 Week high$48.75
52 Week low
$29.24
52 Week low$29.24

Stock Snapshot

Vericel(VCEL) stock is priced at $32.29, giving the company a market capitalization of 1.64B. It carries a P/E multiple of 102.73.

During the trading session on 2026-03-16, Vericel(VCEL) shares reached a daily high of $33.47 and a low of $32.20. At a current price of $32.29, the stock is +0.3% higher than the low and still -3.5% under the high.

Trading activity shows a volume of 505.24K, compared to an average daily volume of 545.03K.

Over the past 52 weeks, Vericel(VCEL) stock has traded between a high of $48.75 and a low of $29.24.

Over the past 52 weeks, Vericel(VCEL) stock has traded between a high of $48.75 and a low of $29.24.

VCEL News

Simply Wall St 2d
How Investors May Respond To Vericel Winning FDA Nod For New MACI Manufacturing Facility

Earlier this month, Vericel Corporation received U.S. FDA approval to begin commercial manufacturing of its MACI cartilage repair therapy at its new Burlington,...

How Investors May Respond To Vericel Winning FDA Nod For New MACI Manufacturing Facility
Simply Wall St 7d
Is Vericel Pricing Justified After A 30% One-Year Share Price Decline - simplywall.st

...

Is Vericel Pricing Justified After A 30% One-Year Share Price Decline - simplywall.st

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own VCEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.